Email UpdatesLiterature Collection
Collection Insights
12K+
References
11K+
Articles
1600+
Grey Literature
4800+
Opioids & SU
The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More
Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).
12780 Results
9881
Responsible Opioid Prescribing for Chronic Pain: Interpreting the CDC Guideline, Understanding New Rhode Island Regulations
Type: Journal Article
Year: 2017
Publication Place: United States
Abstract: New Rhode Island regulations require physicians and other licensed practitioners to make significant adjustments to comply with new requirements for prescribing narcotics for chronic pain. Responding to the opioid epidemic, the new rules are intended to improve patient safety by changing physicians' prescribing patterns. However, the new rules may overlook the importance of treatment-access problems and the importance of buprenorphine products for treating pain and opioid dependence. Empirical data have demonstrated the safety and efficacy of buprenorphine in treating opioid-dependent patients with chronic pain, including those with and without substance abuse histories, but access to buprenorphine treatment remains limited throughout the state. The new regulations call upon physicians to make use of consultation services, which are also of limited availability. Although well intentioned, the new rules may contribute to treatment-access problems, and patients with chronic pain may resort to higher-risk "street" drugs when they are unable to access safe but effective medical treatment. [Full article available at http://rimed.org/rimedicaljournal-2017-10.asp].
Topic(s):
Opioids & Substance Use
See topic collection
9884
Retention and future job intentions of graduate primary care mental health workers: A newly developed role in England
Type: Journal Article
Year: 2007
Publication Place: England
Abstract: OBJECTIVES: Modernization of the English National Health Service (NHS) workforce has led to the introduction of a number of new roles. One such role is the graduate primary care mental health worker (PCMHW). Although generally successful in expanding primary mental health care, several challenges were raised by the initial implementation, including retention and development of effective career pathways for these workers. The aim of this study was to examine retention and future job intentions of graduate PCMHWs at the end of their one-year training. METHODS: Mail surveys of the first cohort of graduate PCMHWs recruited in 2004 were conducted at the beginning and end of their 12-month training. RESULTS: Satisfaction with training courses was generally low. Over half indicated they were likely to leave their graduate PCMHW post within the next few months. However, most intended to stay within the NHS. CONCLUSIONS: After training, problems were highlighted in relation to the quality of the training programmes and lack of development of an effective career pathway. This has serious consequences for the viability of this initiative.
Topic(s):
Education & Workforce
See topic collection
Reference Links: 
View the DOI record for Retention and future job intentions of graduate primary care mental health workers: A newly developed role in England
View DOI Record
View the PubMed citation for Retention and future job intentions of graduate primary care mental health workers: A newly developed role in England9886
Retention in buprenorphine treatment is associated with improved HCV care outcomes
Type: Journal Article
Year: 2017
Publication Place: United States
Topic(s):
Education & Workforce
See topic collection
, Healthcare Disparities
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Retention in buprenorphine treatment is associated with improved HCV care outcomes
View DOI Record
View the PubMed citation for Retention in buprenorphine treatment is associated with improved HCV care outcomes9889
Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine
Type: Journal Article
Year: 2022
Publication Place: United States
Topic(s):
Education & Workforce
See topic collection
, Healthcare Disparities
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine
View DOI Record
View the PubMed citation for Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine9893
Retention in medication-assisted treatment for opiate dependence: A systematic review
Type: Journal Article
Year: 2016
Topic(s):
Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Retention in medication-assisted treatment for opiate dependence: A systematic review
View DOI Record
View the PubMed citation for Retention in medication-assisted treatment for opiate dependence: A systematic review9894
Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic
Type: Journal Article
Year: 2017
Publication Place: Netherlands
Topic(s):
Opioids & Substance Use
See topic collection
9895
Retention in methadone and buprenorphine treatment among African Americans
Type: Journal Article
Year: 2013
Publication Place: United States
Topic(s):
Opioids & Substance Use
See topic collection
, Healthcare Disparities
See topic collection
Reference Links:
View the DOI record for Retention in methadone and buprenorphine treatment among African Americans
View DOI Record
View the PubMed citation for Retention in methadone and buprenorphine treatment among African Americans9897
Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials
Type: Journal Article
Year: 2021
Topic(s):
Financing & Sustainability
See topic collection
, Opioids & Substance Use
See topic collection
9899
Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review
Type: Journal Article
Year: 2014
Publication Place: England
Topic(s):
Opioids & Substance Use
See topic collection
, Healthcare Disparities
See topic collection
9900
Retention of patients in opioid substitution treatment: A systematic review
Type: Journal Article
Year: 2020
Abstract: BACKGROUND: Retention in opioid substitution (OST) treatment is associated with substantial reductions in all cause and overdose mortality. This systematic review aims to identify both protective factors supporting retention in OST, and risk factors for treatment dropout. METHODS: A systematic search was performed using MEDLINE, Embase, PsycInfo, CINAHL and Web of Science (January 2001 to October 2019). Randomised controlled trials (RCTs) and observational cohort studies reporting on retention rates and factors associated with retention in OST were included. Factors associated with treatment retention and dropout were explored according to the Maudsley Addiction Profile. A narrative synthesis is provided. RESULTS: 67 studies were included in this review (4 RCTs and 63 observational cohort studies; N = 294,592), all assessing factors associated with retention in OST or treatment dropout. The median retention rate across observational studies was approximately 57% at 12 months, which fell to 38.4% at three years. Studies included were heterogeneous in nature with respect to treatment setting, type of OST, risk factor assessment, ascertainment of outcome and duration of follow-up. While the presence of such methodological heterogeneity makes it difficult to synthesise results, there is limited evidence to support the influence of a number of factors on retention, including age, substance use, OST drug dose, legal issues, and attitudes to OST. CONCLUSIONS: Younger age, substance use particularly cocaine and heroin use, lower doses of methadone, criminal activity/incarceration, and negative attitudes to MMT appear to be associated with reduced retention in OST. A consensus definition of retention is required to allow for comparability across future studies.
Topic(s):
Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Retention of patients in opioid substitution treatment: A systematic review
View DOI Record
View the PubMed citation for Retention of patients in opioid substitution treatment: A systematic review